Butoctamide succinate

This classification denotes the succinate form of a sedative and hypnotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6MDC25LQSR. European Medicines Agency schedules Butoctamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06028MIG. Butoctamide generally arises in the molecular formula C12H25NO2. The term BUTOCTAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 30, no. 10 1976, list 16.) BUTOCTAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule butoctamide succinate under HS 29241900 and SITC 51471. As of Q4 2014, BUTOCTAMIDE SUCCINATE remains US FDA's Preferred Term for this commodity. SMILES: CCCCC(CC)CNC(=O)CC(C)OC(=O)CCC(=O)O.